Evidence-Based Approaches to HPV Screening Implementation
Cervical cancer screening is evolving globally due to advances in HPV-based testing, self-sampling, and widespread HPV vaccination.
Course Information
This comprehensive online course provides healthcare providers with the latest evidence and practical tools to enhance HPV-based screening, quality assurance, and programme implementation aligned with WHO 2030 goals.
Course Overview
This course is organized in 9 modules:
- Natural history and epidemiology of HPV and cervical cancer
- Principles and methods of HPV-based screening
- Clinical management of HPV-positive women, including triage and follow-up
- Self-sampling strategies to improve coverage and equity
- Impact of HPV vaccination and adaptations required in screening programmes
- Screening considerations for immunosuppressed groups
- Implementation and quality assurance of population-based screening programmes
Methodology
- Modular format with expert-reviewed multimedia lectures
- Interactive quizzes and self-assessments
- Discussion forums with tutor and peer interaction
- Flexible, self-paced online learning
- Certificate awarded upon successful completion
Accreditation
Accredited by the Accreditation Council of Oncology in Europe (ACOE) for 33 Continuing Medical Education (CME) credits.
Who Should Enrol?
Ideal for:
- Gynaecologists and colposcopists involved in diagnosis and treatment
- Nurses and midwives supporting screening and patient education
- Primary care physicians, general practitioners, and family doctors
- Public health officials and programme managers
- Laboratory technicians and technicians performing HPV testing
- Epidemiologists and researchers
Academic Team
Scientific Directors: Dr Laia Bruni & Dr Silvia de Sanjosé
Course Tutor: Dr Claudia Robles
Reviewed by leading international experts
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 847845.
Learning Outcomes
By completing this course, you will gain the skills to implement, manage, and evaluate effective cervical cancer screening programmes using evidence-based approaches.
Subscribe to our newsletter to get news and updates.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959